http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110042164-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2019-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-110042164-B |
titleOfInvention | Lung cancer diagnosis and treatment lncRNA marker |
abstract | The invention discloses a lncRNA marker for diagnosis and treatment, which is RP11-284F 21.10. The invention discovers that the expression of RP11-284F21.10 is remarkably up-regulated in lung adenocarcinoma for the first time, and further proves that RP11-284F21.10 can be used as a potential molecular target for clinical diagnosis of lung adenocarcinoma through a large-sample QPCR experiment. The invention also proves that RP11-284F21.10 influences the proliferation of lung adenocarcinoma cells through CCK 8. |
priorityDate | 2019-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 258.